Sex Differences in Bladder Cancer Immunity
Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
This research explores why bladder cancer affects men more often than women by looking at how immune cells, called T cells, behave differently in male and female bodies.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11141040 on NIH RePORTER |
What this research studies
Bladder cancer affects more men than women, and this project aims to uncover the biological reasons behind this difference, focusing on the immune system. We are looking at how male hormones, called androgens, and genetic factors from sex chromosomes might influence the behavior of immune cells, specifically CD8+ T cells, within bladder tumors. Our goal is to understand if these factors cause T cells to become 'exhausted' and less effective at fighting cancer. By defining these molecular mechanisms, we hope to develop better ways to boost the immune response against bladder cancer for all patients.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to understand biological differences that could eventually inform treatment for individuals with bladder cancer, particularly those interested in how sex differences impact their disease.
Not a fit: Patients whose cancer is not related to the immune system's T cell function or sex-specific biological pathways may not directly benefit from this particular line of research.
Why it matters
Potential benefit: If successful, this work could lead to new, more effective immunotherapy strategies tailored to individual patients, potentially improving outcomes for those with bladder cancer.
How similar studies have performed: While the concept of T cell exhaustion in cancer is established, this specific focus on sexual dimorphism and the role of androgens in bladder cancer immunity represents a novel and underexplored area.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Zihai — Cedars-Sinai Medical Center
- Study coordinator: Li, Zihai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.